Patents: a necessary evil?
Dave Elder explores US patent developments amid growing concerns that current approaches potentially delay generic drugs and biosimilars entering the
Read More
Dave Elder explores US patent developments amid growing concerns that current approaches potentially delay generic drugs and biosimilars entering the
Read MoreCredit…Glenn Harvey By Brian X. Chen Brian X. Chen, who has covered consumer technology for The Times for more than a
Read MoreOctober 16, 2022 – Updated 08:53 pm IST | Chennai Minister of Commerce and Industry said that the patent law
Read MoreHealth Law & Business Sen. Thom Tillis (R-N.C.) is the lead sponsor behind legislation that would reshape patent law. Photographer:
Read MoreUS Law Week Chris Ratcliffe/Bloomberg Scapegoating Patents Won’t Lower Drug Prices OPINION Oct. 17, 2022, 5:00 AM The US patent
Read More